If one could kindly tell me what is wrong with thi
Post# of 148176
For reference: "I hope the CC sheds more light on some numbers because the press release really didn't have much meat in it. Improvement over placebo in 18 of 24 symptoms is good, but how much better? In how many of the patients? Percentages of patients improved would be nice, although the number is small so maybe it's a bit skewed, but if they said 70-90% of patients receiving leronlimab improved....that's a number to get excited about. So far I only know that some symptoms were better over placebo. Maybe they did that so more CC questions would be about the data and less about the 13D group...or they don't have it and still awaiting topline?"